O-glucuronidation, a newly identified metabolic pathway for topotecan and N-desmethyl topotecan

H. Rosing; D.M. van Zomeren; E. Doyle; A. Bult; J.H. Beijnen

O-glucuronidation, a newly identified metabolic pathway for topotecan and N-desmethyl topotecan

H. Rosing, D.M. van Zomeren, E. Doyle, A. Bult, J.H. Beijnen

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	587-592
Number of pages	6
Journal	Anti-Cancer Drugs
Volume	9
Publication status	Published - 1998

Keywords

Medical technology
Farmacie(FARM)
Biomedische technologie en medicijnen
Public Health
Analytical chemistry
Drugmisbruik en verslaving

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{ffdae69d3dfb47609511655cdce8c743,

title = "O-glucuronidation, a newly identified metabolic pathway for topotecan and N-desmethyl topotecan",

keywords = "Medical technology, Farmacie(FARM), Biomedische technologie en medicijnen, Public Health, Analytical chemistry, Drugmisbruik en verslaving",

author = "H. Rosing and {van Zomeren}, D.M. and E. Doyle and A. Bult and J.H. Beijnen",

year = "1998",

language = "Undefined/Unknown",

volume = "9",

pages = "587--592",

journal = "Anti-Cancer Drugs",

issn = "0959-4973",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - O-glucuronidation, a newly identified metabolic pathway for topotecan and N-desmethyl topotecan

AU - Rosing, H.

AU - van Zomeren, D.M.

AU - Doyle, E.

AU - Bult, A.

AU - Beijnen, J.H.

PY - 1998

Y1 - 1998

KW - Medical technology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Public Health

KW - Analytical chemistry

KW - Drugmisbruik en verslaving

M3 - Article

SN - 0959-4973

VL - 9

SP - 587

EP - 592

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

ER -